Frau, M
Ultimately, there is a pressing need to understand whether the beneficial indirect effects of GLP-1RA medications on pancreatic diseases, including PDAC (e.g., weight loss), are negated by direct effects on the pancreas
*Correspondence: Hitoshi Ando, [email protected] This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
could show an improved cardiac performance in sitagliptin-treated rats, which they attributed to increased levels of active BNP (84)
adults were taking GLP-1 medications as of November to lose weight or treat a chronic condition like diabetes, according to a study by the Kaiser Family Foundation
Allow the moisturizer to fully absorb before moving on to the final step